NeoCore Technology Co

NeoCore Technology Co Current Ratio

The Current Ratio of NeoCore Technology Co (4131.TWO) as of Nov 11, 2026 is 13.50. In the previous year, Current Ratio was 1.43 — a change of 842.59% (higher).

Current Ratio

13.50

YoY

842.59%

Last updated:

Current Ratio of NeoCore Technology Co is 2024 13.50 . Current Ratio of NeoCore Technology Co was 2023 1.43 . It decreases by 842.59% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeoCore Technology Co Stock analysis

What does NeoCore Technology Co do? NeoCore Technology Co Ltd generates revenue through the sale of biochips and related biotechnology products. The company develops and manufactures DNA/RNA sample preparation kits, polymerase chain reaction kits, rapid hybridization equipment, biochips, testing reagents, biological preparations, nucleic acid sequencing detection systems, biotechnology control hardware and software, and biomedical materials. These products are primarily sold within Taiwan and exported to Asian and European markets. The company's domestic sales focus on the Taiwanese market while international exports target Asian and European customers. DR. Chip Biotechnology, Inc. operates as the parent company for NeoCore Technology Co Ltd, managing the research, development, manufacturing, and sales of biochips. The business model relies on direct sales of its comprehensive product portfolio to domestic and international clients in the biotechnology sector. The company's product range serves both laboratory and commercial applications within the biotechnology industry. NeoCore Technology Co Ltd's revenue streams include the sale of biochips, DNA/RNA sample preparation kits, polymerase chain reaction kits, and related components. The company's export focus on Asia and Europe drives international sales, while domestic sales in Taiwan form a significant portion of its business. The company's product offerings cater to the needs of biotechnology laboratories and commercial entities requiring advanced biotech solutions. NeoCore Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeoCore Technology Co stock

Current Ratio of NeoCore Technology Co is 13.50 in 2024.

Current Ratio of NeoCore Technology Co changed from 1.43 to 13.50, representing a 842.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio NeoCore Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's NeoCore Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — NeoCore Technology Co

All Key Metrics — NeoCore Technology Co